Update to the International Classification of Diseases, Tenth Revision (ICD-10) Diagnosis Codes for Vaping Related Disorder and Diagnosis and Procedure Codes for the 2019 COVID-19 - Revised

MLN Matters Number: MM11623 Revised
Related CR Release Date: August 21, 2020
Related CR Transmittal Number: R10317OTN
Related Change Request (CR): 11623
Effective Date: April 1, 2020 - For vaping-related and COVID-19 related diagnosis codes included in V37.1 of the MS-DRG Grouper and MCE.; August 1, 2020 - For new procedure codes included in V37.2 of the MS-DRG Grouper and MCE.
Implementation Date: April 6, 2020

Note: CMS revised this article on August 21, 2020, to reflect an updated CR 11623. The CR revision updated the title, Background section and includes new procedure codes in Version 37.2 of the ICD-10 Medicare Severity - Diagnosis Related Groups (MS-DRG) Grouper and ICD-10 Medicare Code Editor (MCE). The CR release date, transmittal number and link to the transmittal also changed. All other information remains the same.

CR 11623 adds new ICD-10-Clinical Modification (CM) codes for vaping related disorder and 2019 Novel Coronavirus (COVID-19) and ICD-10 Procedure Coding System (PCS) codes to the Medicare Severity - Diagnosis Related Groups (MS-DRG) Grouper and Medicare Code Editor (MCE) effective for discharges on and after April 1, 2020. Twelve new procedure codes to describe the introduction or infusion of therapeutics, including remdesivir and convalescent plasma into the ICD-10-PCS are effective for discharges on and after August 1, 2020. Make sure your billing staffs are aware of these changes related to the new code.

View the complete CMS Medicare Learning Network (MLN) Matters (MM)11623.

 

            Last Updated Tue, 25 Aug 2020 14:41:54 +0000